Overview
Wesselsbron fever, caused by the Wesselsbron disease virus (WSLV), is a zoonotic viral disease primarily affecting livestock but with potential implications for human health. First described in South Africa, this flavivirus has been predominantly reported in Sub-Saharan Africa, where it circulates among various animal hosts including cattle, sheep, goats, and wildlife. Despite sporadic human cases reported over the years, the clinical impact on humans remains relatively understudied compared to its veterinary significance. The expanding geographical range of its primary vector, Aedes mosquitoes, particularly in tropical and subtropical regions of Africa, raises concerns about increased human exposure and potential outbreaks. Understanding the pathophysiology, clinical presentation, and complications of Wesselsbron fever is crucial for early recognition and management, especially in occupational settings where exposure risk is higher.
Pathophysiology
The pathophysiology of Wesselsbron fever involves complex interactions between the virus and host tissues, particularly highlighting its neurotropic properties. Experimental studies in animal models have demonstrated WSLV's capability to invade neural tissues, suggesting a potential for neurological complications in human infections [PMID:39547415]. This neuro-invasion capability implies that the virus may not be confined to peripheral sites but can disseminate to the central nervous system (CNS), leading to severe neurological manifestations. This hypothesis is further supported by observations in a laboratory setting where occupational exposure resulted in intense headaches, memory loss, and severe muscle spasms, indicative of CNS involvement [PMID:39547415]. Additionally, the impact on fetal development underscores the virus's teratogenic potential. In a study where pregnant cows were inoculated with WSLV, one calf exhibited marked porencephaly (a congenital defect characterized by a fluid-filled cavity in the brain) and cerebellar hypoplasia, indicating that in utero exposure can lead to severe congenital anomalies [PMID:551364]. These findings collectively suggest that WSLV poses significant risks beyond acute febrile illness, extending to long-term neurological sequelae and developmental disorders.
Epidemiology
The epidemiology of Wesselsbron fever is characterized by sporadic human cases and widespread animal infections across Sub-Saharan Africa. Despite the limited number of reported human cases—approximately 31 documented cases since its discovery (Karabatsos, 1985; Diagne et al., 2017; Weyer et al., 2013)—the virus has been isolated from a diverse range of hosts including livestock and wildlife, indicating robust zoonotic transmission dynamics [PMID:39547415]. The primary vectors, Aedes mosquitoes, are widely distributed in tropical and subtropical regions, suggesting that human exposure could increase with expanding vector habitats. This geographical spread and vector distribution imply a potential for greater human incidence in areas where surveillance and reporting might be less robust. The sporadic nature of human cases may also reflect underreporting or asymptomatic infections, complicating efforts to fully assess the true burden of the disease. Consequently, public health strategies should focus on enhancing surveillance in regions with suitable vector environments to better understand and mitigate the risk of outbreaks.
Clinical Presentation
In humans, Wesselsbron fever typically presents as an influenza-like illness with a relatively short duration of fever and mild systemic symptoms. Patients often experience a sudden onset of fever, accompanied by nonspecific symptoms such as malaise, headache, and myalgia [PMID:39547415]. Additionally, a rash and arthralgia are frequently reported, contributing to the clinical overlap with other febrile illnesses common in endemic regions. The acute phase symptoms are generally self-limiting, resolving within a week without specific antiviral treatment, though supportive care may be necessary for symptom management. In contrast, the clinical manifestations in cattle are less severe, with only a few cases showing transient fever and abortion as primary symptoms, while most animals exhibit no overt clinical signs [PMID:551364]. This disparity highlights the species-specific variability in disease expression, underscoring the need for differential diagnosis in veterinary and human clinical settings. Early recognition of these symptoms is crucial for timely intervention and to prevent potential complications, particularly in high-risk occupational groups.
Complications
While Wesselsbron fever typically presents with mild to moderate symptoms, certain scenarios can lead to more severe complications, particularly in contexts of heightened exposure or vulnerability. Occupational exposure, such as in laboratory settings, has been linked to more pronounced manifestations, including neurological symptoms like intense headaches, memory disturbances, and severe muscle spasms [PMID:39547415]. These neurological complications suggest that prolonged or intense viral exposure might facilitate CNS invasion, leading to chronic sequelae. Furthermore, the teratogenic potential of WSLV is evident from experimental studies where in utero exposure resulted in severe congenital anomalies in calves, specifically porencephaly and cerebellar hypoplasia [PMID:551364]. These findings highlight the critical risk to pregnant women and fetuses, emphasizing the need for stringent protective measures in endemic areas. Clinicians should be vigilant for these complications, especially in pregnant women and individuals with occupational risks, to ensure appropriate monitoring and intervention.
Diagnosis
Diagnosing Wesselsbron fever in clinical practice relies on a combination of clinical suspicion, epidemiological context, and laboratory confirmation. Given the nonspecific nature of initial symptoms, clinical diagnosis often hinges on recognizing the epidemiological risk factors, such as recent travel to endemic areas or occupational exposure to infected animals [PMID:39547415]. Laboratory confirmation typically involves serological testing, including enzyme-linked immunosorbent assays (ELISA) and neutralization tests, which can detect specific antibodies against WSLV [PMID:39547415]. Viral RNA detection through reverse transcription polymerase chain reaction (RT-PCR) from blood or cerebrospinal fluid (CSF) can also be employed, particularly in suspected neurological complications [PMID:39547415]. However, due to the limited availability of diagnostic tools and the sporadic nature of human cases, definitive diagnosis can sometimes be challenging. In clinical practice, a high index of suspicion and integration of clinical history with laboratory evidence are essential for accurate identification and management of the disease.
Management
The management of Wesselsbron fever primarily focuses on supportive care due to the lack of specific antiviral treatments. Symptomatic relief is crucial, addressing fever, pain, and general malaise through antipyretics and analgesics [PMID:39547415]. For patients experiencing severe neurological symptoms, close monitoring in a clinical setting may be necessary to manage complications such as seizures or altered mental status. Hydration and rest are fundamental components of supportive care, especially in managing the systemic effects of the illness. In occupational settings or high-risk environments, preventive measures are paramount. These include personal protective equipment (PPE) use, vector control strategies to reduce mosquito populations, and education on avoiding exposure to infected animals [PMID:39547415]. Given the potential for severe complications, particularly in pregnant women and those with heightened exposure, early recognition and prompt medical attention are critical to mitigate adverse outcomes.
Key Recommendations
References
1 Faye M, Di Paola N, Dia M, Sall AA, Faye O. Molecular epidemiology and pathogenicity of Wesselsbron virus circulating in Africa. Virus research 2024. link 2 Coetzer JA, Theodoridis A, Herr S, Kritzinger L. Wesselsbron disease: a cause of congenital porencephaly and cerebellar hypoplasia in calves. The Onderstepoort journal of veterinary research 1979. link
2 papers cited of 3 indexed.